In January 2019 Lancet has published the paper “Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial” (1). The main purpose of this prospective trial was to asses if fluoxetine [a selective serotonin reuptake inhibitor (SSRI) drug] could improve recovery after stroke.
FOCUS trial: results, potentialities and limits
Saba, LucaPrimo
;Balestrieri, Antonella;Serra, Alessandra;Politi, Carola;Murgia, Alessandro;Mannelli, Lorenzo
2019-01-01
Abstract
In January 2019 Lancet has published the paper “Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial” (1). The main purpose of this prospective trial was to asses if fluoxetine [a selective serotonin reuptake inhibitor (SSRI) drug] could improve recovery after stroke.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
atm-07-S3-S152(1).pdf
Solo gestori archivio
Dimensione
166.12 kB
Formato
Adobe PDF
|
166.12 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
